2023 annual financial data
Amneal Pharmaceuticals 2023 Operating margin
Amneal Pharmaceuticals 2023 operating margin with verified reported values.
Direct answer
Operating margin was 8.54%.
Operating income was 204,374,000 USD and net income was -83,993,000 USD.
Operating cash flow was 345,577,000 USD.
Get free Amneal Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,393,607,000 USD
- Operating income
- 204,374,000 USD
- Net income
- -83,993,000 USD
- Operating cash flow
- 345,577,000 USD